cbdMD, Inc.
$0.81
▲
2.37%
2026-04-21 10:23:00
www.cbdmd.com
ASE: YCBD
Explore cbdMD, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$7.12 M
Current Price
$0.81
52W High / Low
$2.56 / $0.47
Stock P/E
—
Book Value
$0.89
Dividend Yield
0%
ROCE
-29.93%
ROE
-43.36%
Face Value
—
EPS
$0.6
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
42
Beta
2.1
Debt / Equity
6.58
Current Ratio
2.94
Quick Ratio
1.2
Forward P/E
-0.76
Price / Sales
0.37
Enterprise Value
$4.34 M
EV / EBITDA
-3.37
EV / Revenue
0.23
Rating
None
Target Price
$2
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Aurora Cannabis Inc. | $3.72 | — | $285.82 M | — | 1.34% | -15.51% | $9.33 / $4.29 | $6.8 |
| 2. | Biofrontera Inc. | $1.09 | — | $12.81 M | — | -68.08% | -1.41% | $1.19 / $0.54 | $0.9 |
| 3. | Incannex Healthcare Inc. | $3.84 | — | $51 M | — | — | -1.3% | $49.8 / $2.4 | $6.13 |
| 4. | Aquestive Therapeutics, Inc. | $4.24 | — | $527.23 M | — | -62.98% | 178.61% | $7.55 / $2.12 | $-0.28 |
| 5. | Akanda Corp. | $3.42 | — | $1.89 M | — | -102.48% | -60.86% | $209.03 / $2.29 | $22.67 |
| 6. | Esperion Therapeutics, Inc. | $2.02 | — | $510.15 M | — | 36.51% | 6.57% | $4.17 / $0.69 | $-1.23 |
| 7. | Talphera, Inc. | $0.78 | — | $40.17 M | — | -52.04% | -1.15% | $1.57 / $0.38 | $0.34 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 5.02 M | 4.72 M | 4.61 M | 4.75 M | 5.11 M | — |
| Operating Profit | -0.29 M | -0.69 M | -0.9 M | -0.49 M | -0.09 M | — |
| Net Profit | -0.28 M | -0.68 M | -0.9 M | -0.48 M | 0.02 M | — |
| EPS in Rs | -0.03 | -0.06 | -0.09 | -0.05 | 0 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 19.19 M | 19.48 M | 24.16 M | 35.4 M |
| Operating Profit | -2.16 M | -3.32 M | -9.27 M | -17.31 M |
| Net Profit | -2.04 M | -3.7 M | -22.94 M | -70.08 M |
| EPS in Rs | -0.19 | -0.35 | -2.19 | -6.68 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.42 M | 10.58 M | 16.2 M | 40.79 M |
| Total Liabilities | 3.19 M | 8.62 M | 7.16 M | 9.37 M |
| Equity | 7.23 M | 1.96 M | 9.03 M | 31.42 M |
| Current Assets | 6.55 M | 6.39 M | 8.07 M | 16.01 M |
| Current Liabilities | 3.19 M | 8.62 M | 4.67 M | 5.29 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -1.45 M | -0.35 M | -4.3 M | -14.97 M |
| Investing CF | -0.18 M | -0.29 M | 0.7 M | -0.69 M |
| Financing CF | 1.45 M | 1.3 M | -1.32 M | -4.04 M |
| Free CF | -1.64 M | -0.64 M | -4.6 M | -15.66 M |
| Capex | -0.18 M | -0.29 M | -0.3 M | -0.69 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -19.35% | -31.77% | — | — |
| Earnings Growth % | 83.87% | 67.27% | — | — |
| Profit Margin % | -18.99% | -94.96% | -197.96% | — |
| Operating Margin % | -17.02% | -38.37% | -48.9% | — |
| Gross Margin % | 61.57% | 62.01% | 63.09% | — |
| EBITDA Margin % | -7.67% | -26.25% | -40.51% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-05-07 | 1:0.125 |
| 2023-04-25 | 1:0.0222222 |